- Home
- ZENA vs STRO Comparison
ZENA vs STRO Comparison
Compare ZENA & STRO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ZENA
- STRO
- Stock Information
- Founded
- ZENA 2017
- STRO 2003
- Country
- ZENA Canada
- STRO United States
- Employees
- ZENA N/A
- STRO N/A
- Industry
- ZENA
- STRO Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- ZENA
- STRO Health Care
- Exchange
- ZENA NYSE
- STRO Nasdaq
- Market Cap
- ZENA 51.9M
- STRO 50.0M
- IPO Year
- ZENA N/A
- STRO 2018
- Fundamental
- Price
- ZENA $2.50
- STRO $0.84
- Analyst Decision
- ZENA
- STRO Buy
- Analyst Count
- ZENA 0
- STRO 7
- Target Price
- ZENA N/A
- STRO $6.83
- AVG Volume (30 Days)
- ZENA 207.5K
- STRO 1.7M
- Earning Date
- ZENA 01-01-0001
- STRO 05-12-2025
- Dividend Yield
- ZENA N/A
- STRO N/A
- EPS Growth
- ZENA N/A
- STRO N/A
- EPS
- ZENA N/A
- STRO N/A
- Revenue
- ZENA $1,364,714.00
- STRO $62,043,000.00
- Revenue This Year
- ZENA N/A
- STRO N/A
- Revenue Next Year
- ZENA N/A
- STRO $1.29
- P/E Ratio
- ZENA N/A
- STRO N/A
- Revenue Growth
- ZENA 7.43
- STRO N/A
- 52 Week Low
- ZENA $1.41
- STRO $0.52
- 52 Week High
- ZENA $12.43
- STRO $5.17
- Technical
- Relative Strength Index (RSI)
- ZENA N/A
- STRO 57.04
- Support Level
- ZENA N/A
- STRO $0.52
- Resistance Level
- ZENA N/A
- STRO $0.78
- Average True Range (ATR)
- ZENA 0.00
- STRO 0.10
- MACD
- ZENA 0.00
- STRO 0.06
- Stochastic Oscillator
- ZENA 0.00
- STRO 99.87
About ZENA ZENATECH INC
ZenaTech Inc is a enterprise software technology company that specializes in mission-critical cloud-based applications integrated with smart hardware to deliver innovative solutions across diverse industries. The Company operates in software development technology, sales, and distribution. The Company is also developing a drone manufacturing, sales, and distribution business. The company operates in two segments which is software development technology, sales, and distribution, as well as drone manufacturing, sales, and distribution.
About STRO Sutro Biopharma Inc.
Sutro Biopharma Inc is a clinical-stage drug discovery, development, and manufacturing company. It is mainly engaged in the development of biopharmaceutical products. The company manufactures next-generation protein therapeutics for cancer and autoimmune disorders through its proprietary integrated cell-free protein synthesis platform, XpressCF. Products offered by the company include STRO-001 for patients with multiple myeloma and non-Hodgkin lymphoma and STRO-002 for the treatment of ovarian and endometrial cancers. The company also pipeline contains STRO-004, STRO-006, STRO-00X, STRO-00Y, STRO-003, VAX24, VAX31, and Others.